Atlas Trials

A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

Clinical trial NCT07697846 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07697846
Sponsor
Beijing QL Biopharmaceutical Co.,Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Overweight, Obesity
Start date
2026-07-18
Primary completion
2027-01-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.